421 related articles for article (PubMed ID: 18570254)
41. Inhibition of tumor formation and metastasis by a monoclonal antibody against lymphatic vessel endothelial hyaluronan receptor 1.
Hara Y; Torii R; Ueda S; Kurimoto E; Ueda E; Okura H; Tatano Y; Yagi H; Ohno Y; Tanaka T; Masuko K; Masuko T
Cancer Sci; 2018 Oct; 109(10):3171-3182. PubMed ID: 30058195
[TBL] [Abstract][Full Text] [Related]
42. Angiopoietin-1 promotes LYVE-1-positive lymphatic vessel formation.
Morisada T; Oike Y; Yamada Y; Urano T; Akao M; Kubota Y; Maekawa H; Kimura Y; Ohmura M; Miyamoto T; Nozawa S; Koh GY; Alitalo K; Suda T
Blood; 2005 Jun; 105(12):4649-56. PubMed ID: 15705793
[TBL] [Abstract][Full Text] [Related]
43. Distribution of lymphatic vessel network in normal urinary bladder.
Matsumoto K; Soh S; Satoh T; Iwamura M; Ishikawa Y; Ishii T; Baba S
Urology; 2008 Sep; 72(3):706-10. PubMed ID: 18342921
[TBL] [Abstract][Full Text] [Related]
44. Expression of lymphatic vascular endothelial hyaluronan receptor-1 (LYVE-1) in the human placenta.
Gu B; Alexander JS; Gu Y; Zhang Y; Lewis DF; Wang Y
Lymphat Res Biol; 2006; 4(1):11-7. PubMed ID: 16569201
[TBL] [Abstract][Full Text] [Related]
45. Mouse LYVE-1 is an endocytic receptor for hyaluronan in lymphatic endothelium.
Prevo R; Banerji S; Ferguson DJ; Clasper S; Jackson DG
J Biol Chem; 2001 Jun; 276(22):19420-30. PubMed ID: 11278811
[TBL] [Abstract][Full Text] [Related]
46. Multipotent mesenchymal stem cells acquire a lymphendothelial phenotype and enhance lymphatic regeneration in vivo.
Conrad C; Niess H; Huss R; Huber S; von Luettichau I; Nelson PJ; Ott HC; Jauch KW; Bruns CJ
Circulation; 2009 Jan; 119(2):281-9. PubMed ID: 19118255
[TBL] [Abstract][Full Text] [Related]
47. Stewart-Treves syndrome angiosarcoma expresses phenotypes of both blood and lymphatic capillaries.
Stanczyk M; Gewartowska M; Swierkowski M; Grala B; Maruszynski M
Chin Med J (Engl); 2013 Jan; 126(2):231-7. PubMed ID: 23324269
[TBL] [Abstract][Full Text] [Related]
48. Development of murine hepatic sinusoidal endothelial cells characterized by the expression of hyaluronan receptors.
Nonaka H; Tanaka M; Suzuki K; Miyajima A
Dev Dyn; 2007 Aug; 236(8):2258-67. PubMed ID: 17626278
[TBL] [Abstract][Full Text] [Related]
49. Improved semiautomatic method for morphometry of angiogenesis and lymphangiogenesis in corneal flatmounts.
Bock F; Onderka J; Hos D; Horn F; Martus P; Cursiefen C
Exp Eye Res; 2008 Nov; 87(5):462-70. PubMed ID: 18789928
[TBL] [Abstract][Full Text] [Related]
50. In vivo imaging of lymph node lymphangiogenesis by immuno-positron emission tomography.
Mumprecht V; Detmar M
Methods Mol Biol; 2013; 961():129-40. PubMed ID: 23325639
[TBL] [Abstract][Full Text] [Related]
51. Lymphangiogenesis following obstruction of large postnodal lymphatics in sheep.
Jila A; Kim H; Nguyen VP; Dumont DJ; Semple J; Armstrong D; Seto E; Johnston M
Microvasc Res; 2007 May; 73(3):214-23. PubMed ID: 17188720
[TBL] [Abstract][Full Text] [Related]
52. High VEGFR-3-positive circulating lymphatic/vascular endothelial progenitor cell level is associated with poor prognosis in human small cell lung cancer.
Bogos K; Renyi-Vamos F; Dobos J; Kenessey I; Tovari J; Timar J; Strausz J; Ostoros G; Klepetko W; Ankersmit HJ; Lang G; Hoda MA; Nierlich P; Dome B
Clin Cancer Res; 2009 Mar; 15(5):1741-6. PubMed ID: 19240177
[TBL] [Abstract][Full Text] [Related]
53. Age-related changes in murine limbal lymphatic vessels and corneal lymphangiogenesis.
Hos D; Bachmann B; Bock F; Onderka J; Cursiefen C
Exp Eye Res; 2008 Nov; 87(5):427-32. PubMed ID: 18755186
[TBL] [Abstract][Full Text] [Related]
54. Inflammation-induced uptake and degradation of the lymphatic endothelial hyaluronan receptor LYVE-1.
Johnson LA; Prevo R; Clasper S; Jackson DG
J Biol Chem; 2007 Nov; 282(46):33671-33680. PubMed ID: 17884820
[TBL] [Abstract][Full Text] [Related]
55. Isolation, purification, and heterogeneity of human lymphatic endothelial cells from different tissues.
Garrafa E; Trainini L; Benetti A; Saba E; Fezzardi L; Lorusso B; Borghetti P; Bottio T; Ceri E; Portolani N; Bonardlli S; Giulini SM; Annibale G; Corradi A; Imberti L; Caruso A
Lymphology; 2005 Dec; 38(4):159-66. PubMed ID: 16515224
[TBL] [Abstract][Full Text] [Related]
56. Lymphatic vessel assembly is impaired in Aspp1-deficient mouse embryos.
Hirashima M; Sano K; Morisada T; Murakami K; Rossant J; Suda T
Dev Biol; 2008 Apr; 316(1):149-59. PubMed ID: 18304521
[TBL] [Abstract][Full Text] [Related]
57. Expression and quantification of LYVE-1 in human colorectal cancer.
Gao F; Lu YM; Cao ML; Liu YW; He YQ; Wang Y
Clin Exp Med; 2006 Jun; 6(2):65-71. PubMed ID: 16820993
[TBL] [Abstract][Full Text] [Related]
58. Abnormal Shh and FOXC2 expression correlates with aberrant lymphatic development in human fetuses with increased nuchal translucency.
de Mooij YM; van den Akker NM; Bekker MN; Bartelings MM; Wisse LJ; van Vugt JM; Gittenberger-de Groot AC
Prenat Diagn; 2009 Sep; 29(9):840-6. PubMed ID: 19548265
[TBL] [Abstract][Full Text] [Related]
59. Normal lymphatic development and function in mice deficient for the lymphatic hyaluronan receptor LYVE-1.
Gale NW; Prevo R; Espinosa J; Ferguson DJ; Dominguez MG; Yancopoulos GD; Thurston G; Jackson DG
Mol Cell Biol; 2007 Jan; 27(2):595-604. PubMed ID: 17101772
[TBL] [Abstract][Full Text] [Related]
60. Immunohistochemical demonstration of Angiopoietin-2 in lymphatic vascular development.
Shimoda H
Histochem Cell Biol; 2009 Feb; 131(2):231-8. PubMed ID: 18836739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
